CD82 and neoplasm: It was demonstrated that compared with the control group, tumor growth was not suppressed when mice were injected with KAI1/CD82+ EPCs (endothelial progenitor cells), but the incidence of lung metastasis and the number of metastatic foci on the lung surface were significantly reduced [14].